Prognosis
Russia’s Richest Man Seeks Global Market for Local Covid-19 Drug
- Potanin’s Petrovax to begin testing Covid-19 drug in Slovakia
- No medicines to treat Covid-19 have been approved by WHO yet
This article is for subscribers only.
A Russian pharmaceutical company owned by the country’s richest man, Vladimir Potanin, is hoping its domestically-developed Covid-19 drug can help it break into lucrative export markets.
NPO Petrovax Pharm LLC’s medication Polyoxidonium, which is used for respiratory virus infections and as a vaccine booster, is undergoing Phase 3 testing on Covid-19 patients in Russia and will soon expand the trials to Slovakia, the company’s president, Mikhail Tsyferov, said in an interview.